Guided Therapeutics Inc Stock OTC Bulletin Board
Equities
US40171F1057
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2022 | 13K | Sales 2023 | 98K | Capitalization | 8.31M |
---|---|---|---|---|---|
Net income 2022 | -4M | Net income 2023 | -3M | EV / Sales 2022 | 1,118 x |
Net cash position 2022 | 50K | Net Debt 2023 | 1.47M | EV / Sales 2023 | 99.7 x |
P/E ratio 2022 |
-1.96
x | P/E ratio 2023 |
-2.09
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.3% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 68 | 92-10-26 |
Founder | 68 | 92-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Imhoff
BRD | Director/Board Member | 74 | 06-04-09 |
Richard Blumberg
BRD | Director/Board Member | 67 | 16-11-09 |
Mark Faupel
CEO | Chief Executive Officer | 68 | 92-10-26 |
1st Jan change | Capi. | |
---|---|---|
+8.35% | 209B | |
+9.41% | 175B | |
+11.75% | 131B | |
+19.34% | 99.98B | |
-0.84% | 61.12B | |
+15.08% | 52.34B | |
-2.10% | 46.5B | |
+0.10% | 39.24B | |
+11.50% | 38.47B |